GEN - Genetic Engineering & Biotech NewsOriginal article
Combined Phage Therapy and FMT Reduces Recurrent UTIs and Antibiotic Use in First Human Case Series
Data ReadoutpositivePhage TherapyFecal Microbiota Transplantation (FMT)Positive
AI Analysis
Summary
A first-in-human case series demonstrated that combined phage therapy and fecal microbiota transplantation reduced antibiotic use and improved quality of life in three women with recurrent urinary tract infections. The results support advancement to future clinical trials.
Clinical Trial Data
Primary Endpoint
Met
Patients
3
Outcome Details
Combined phage therapy and FMT reduced antibiotic use and improved quality of life in three women with recurrent UTIs
Importance:4/10
Sentiment:
0.65
phage therapyfecal microbiota transplantationrecurrent UTIantibiotic resistancecase seriesclinical trial support
Read the original article
Published by GEN - Genetic Engineering & Biotech News on August 3, 2026 6:32 PM